Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.1B | 1.0B | 963.9M | 921.0M |
| Cost of revenue | 274.0M | 255.1M | 237.4M | 225.0M |
| Gross profit | 784.5M | 755.1M | 726.5M | 696.0M |
| Operating expense | ||||
| Research & development | 315.1M | 275.6M | 250.9M | 235.2M |
| Selling general and admin | 554.7M | 535.2M | 461.9M | 453.8M |
| Other operating expenses | — | — | — | — |
| Operating income | -85.3M | -55.7M | 13.7M | 6.9M |
| Non operating interest income | ||||
| Income | 46.6M | 52.2M | 51.5M | 45.9M |
| Expense | 6.7M | 6.6M | 6.5M | 6.5M |
| Other income expense | -1.1M | -429K | -1.0M | 7.7M |
| Pretax income | -46.5M | -10.5M | 57.6M | 53.9M |
| Tax provision | 46.3M | 6.3M | 10.9M | 7.7M |
| Net income | -92.7M | -16.8M | 46.7M | 46.3M |
| Basic EPS | — | -0.1 | 0.2 | 0.2 |
| Diluted EPS | — | -0.1 | 0.2 | 0.2 |
| Basic average shares | — | 12.6M | 12.5M | 12.4M |
| Diluted average shares | — | 12.6M | 12.9M | 12.8M |
| EBITDA | 17.6M | 51.3M | 116.7M | 109.1M |
| Net income from continuing op. | -92.7M | -16.8M | 46.7M | 46.3M |
| Minority interests | 449K | -3K | 323K | -3.4M |
| Preferred stock dividends | — | — | — | — |